Additionally, VCA‐IgA‐positive non‐NPC individuals exhibited a medium INSL5 plasma level between the NPC cohort and VCA‐IgA‐negative normal individuals. The gene discussed is CD79A; the disease is nasopharyngeal carcinoma.